August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
August 2, 2011 – The U.S. Food and Drug Administration said it recently cleared Abbott Vascular’s RX Herculink Elite ...
July 14, 2011 — The U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3 ...
June 14, 2011 – New performance measures for adults with coronary artery disease (CAD) and hypertension were released ...
May 19, 2011 - Results from a study validating Cheetah Medical's noninvasive NICOM system specifically for use in ...
May 6, 2011 – A substance secreted by the heart that is associated with congestive heart failure and renal failure is ...
April 21, 2011 – A new angiotensin II receptor blocker (ARB) has been approved by the U.S. Food and Drug ...
March 30, 2011 – Interventional radiologists have completed the first human randomized controlled trial of ...
March 18, 2011 – Researchers have found a link between high blood pressure and a greater drop in average walking ...
March 11, 2011 – Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another ...
March 8, 2011 – The U.S. Food and Drug Administration (FDA) announced monthly liver enzyme tests are no longer ...
March 1, 2011 – The U.S. Food and Drug Administration (FDA) approved azilsartan medoxomil to treat high blood ...
December 27, 2010 – The U.S. Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and ...
December 21, 2010 – A once-daily, three-in-one combination blood pressure treatment has been approved in Germany ...
December 13, 2010 – Based on emerging safety information, the pulmonary arterial hypertension (PAH) drug ...